Patent Foramen Ovale Closure Decreases the Incidence but Not the Size of New Brain Infarction on Magnetic Resonance Imaging: An Analysis of the REDUCE Trial

BACKGROUND AND PURPOSE: Randomized patent foramen ovale closure trials have used open-label end point ascertainment which increases the risk of bias and undermines confidence in the conclusions. The Gore REDUCE trial prospectively performed baseline and follow-up magnetic resonance imaging (MRIs) fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Messé, Steven R., Erus, Guray, Bilello, Michel, Davatzikos, Christos, Andersen, Grethe, Iversen, Helle K., Roine, Risto O., Sjöstrand, Christina, Rhodes, John F., Søndergaard, Lars, Kasner, Scott E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545852/
https://www.ncbi.nlm.nih.gov/pubmed/34455822
http://dx.doi.org/10.1161/STROKEAHA.121.034451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545852/
https://www.ncbi.nlm.nih.gov/pubmed/34455822
http://dx.doi.org/10.1161/STROKEAHA.121.034451

Ejemplares similares